Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David W Vaughn

Showing results (41-50 of 94) with videos related to

Pageof 10
Sort By:
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severityIva Zivna, Sharone Green, David W Vaughn, et al.
The Journal of General Virology|March 11, 2006
Structure and age of genetic diversity of dengue virus type 2 in ThailandChunlin Zhang, Mammen P Mammen, Piyawan Chinnawirotpisan, et al.
The Pediatric Infectious Disease Journal|July 18, 2012
Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicityJoanne M Langley, Dennis Reich, Naresh Aggarwal, et al.
Military Medicine|March 13, 2008
Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. militaryW Neal Burnette, Charles H Hoke, John Scovill, et al.
The Journal of Infectious Diseases|June 27, 2002
Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildrenMarlou M Mangada, Timothy P Endy, Ananda Nisalak, et al.
The Journal of Infectious Diseases|May 17, 2006
Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccinationWellington Sun, Ananda Nisalak, Montip Gettayacamin, et al.
Vaccine|September 4, 2012
US Military contributions to the global response to pandemic chikungunyaCharles H Hoke, Judy Pace-Templeton, Phillip Pittman, et al.
Emerging Infectious Diseases|May 9, 2002
Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian childrenY Meng Chhour, Gaye Ruble, Rathavuth Hong, et al.
Vaccine|December 3, 2014
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trialJoanne M Langley, Louise Frenette, Robert Jeanfreau, et al.
The Journal of Infectious Diseases|July 5, 2005
Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infectionKamolwish Laoprasopwattana, Daniel H Libraty, Timothy P Endy, et al.
Pageof 10

Showing results (41-50 of 94) with videos related to

Sort By:
Pageof 10
Journal of Immunology (Baltimore, Md. : 1950)|May 23, 2002
T cell responses to an HLA-B*07-restricted epitope on the dengue NS3 protein correlate with disease severityIva Zivna, Sharone Green, David W Vaughn, et al.
The Journal of General Virology|March 11, 2006
Structure and age of genetic diversity of dengue virus type 2 in ThailandChunlin Zhang, Mammen P Mammen, Piyawan Chinnawirotpisan, et al.
The Pediatric Infectious Disease Journal|July 18, 2012
Randomized, multicenter trial of a single dose of AS03-adjuvanted or unadjuvanted H1N1 2009 pandemic influenza vaccine in children 6 months to <9 years of age: safety and immunogenicityJoanne M Langley, Dennis Reich, Naresh Aggarwal, et al.
Military Medicine|March 13, 2008
Infectious diseases investment decision evaluation algorithm: a quantitative algorithm for prioritization of naturally occurring infectious disease threats to the U.S. militaryW Neal Burnette, Charles H Hoke, John Scovill, et al.
The Journal of Infectious Diseases|June 27, 2002
Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildrenMarlou M Mangada, Timothy P Endy, Ananda Nisalak, et al.
The Journal of Infectious Diseases|May 17, 2006
Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccinationWellington Sun, Ananda Nisalak, Montip Gettayacamin, et al.
Vaccine|September 4, 2012
US Military contributions to the global response to pandemic chikungunyaCharles H Hoke, Judy Pace-Templeton, Phillip Pittman, et al.
Emerging Infectious Diseases|May 9, 2002
Hospital-based diagnosis of hemorrhagic fever, encephalitis, and hepatitis in Cambodian childrenY Meng Chhour, Gaye Ruble, Rathavuth Hong, et al.
Vaccine|December 3, 2014
Immunogenicity of heterologous H5N1 influenza booster vaccination 6 or 18 months after primary vaccination in adults: a randomized controlled clinical trialJoanne M Langley, Louise Frenette, Robert Jeanfreau, et al.
The Journal of Infectious Diseases|July 5, 2005
Dengue Virus (DV) enhancing antibody activity in preillness plasma does not predict subsequent disease severity or viremia in secondary DV infectionKamolwish Laoprasopwattana, Daniel H Libraty, Timothy P Endy, et al.
Pageof 10